«

»

California Attorney General Sues Drugmakers Over Inflated Insulin Prices

California Attorney General Rob Bonta on Thursday sued the six major companies that dominate the U.S. insulin market, ratcheting up the state’s assault on a profitable industry for artificially jacking up prices and making the indispensable drug less accessible for diabetes patients.  The 47-page civil complaint alleges three pharmaceutical companies that control the insulin market — Eli Lilly and Co., Sanofi, and Novo Nordisk — are violating California law by unfairly and illegally driving up the cost of the drug. It also targets three distribution middlemen known as pharmacy benefit managers: CVS Caremark, Express Scripts, and OptumRx.  “We’re going to lev...

Read the full post at Syndicate – Kaiser Health News
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive